Patents by Inventor Mark Richard Underwood

Mark Richard Underwood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral therapy
    Patent number: 11234985
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: February 1, 2022
    Inventor: Mark Richard Underwood
  • ANTIVIRAL THERAPY
    Publication number: 20210401850
    Abstract: The invention relates to a combination comprising (3S, 11aR)—N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo [3,2-a] pyrido [1,2-d] pyrazine-8-carboxamide, or a pharmaceutically acceptable salt thereof and rilpivirine, along with therapeutic methods administering the same.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 30, 2021
    Inventor: Mark Richard Underwood
  • COMBINATIONS AND USES AND TREATMENTS THEREOF
    Publication number: 20200246351
    Abstract: Methods for treating or preventing HIV in a patient using a combination of bictegravir and lamivudine and optionally with other anti-HIV agents are disclosed, as well as compositions containing such compounds.
    Type: Application
    Filed: August 2, 2018
    Publication date: August 6, 2020
    Inventors: Mark I. COCKETT, Eugene L. STEWART, Mark Richard UNDERWOOD, Cindy L. VAVRO
  • ANTIVIRAL THERAPY
    Publication number: 20200230147
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: March 31, 2020
    Publication date: July 23, 2020
    Inventor: Mark Richard UNDERWOOD
  • COMBINATIONS AND USES AND TREATMENTS
    Publication number: 20200171039
    Abstract: Methods for treating or preventing HIV in a patient using a combination of bictegravir and emtricitabine and optionally with other anti-HIV agents are disclosed, as well as compositions containing such compounds.
    Type: Application
    Filed: August 2, 2018
    Publication date: June 4, 2020
    Inventors: Mark I. COCKETT, Eugene L. STEWART, Mark Richard UNDERWOOD, Cindy L. VAVRO
  • Antiviral therapy
    Patent number: 10426780
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: October 1, 2019
    Assignee: ViiV Healthcare Company
    Inventor: Mark Richard Underwood
  • ANTIVIRAL THERAPY
    Publication number: 20180200254
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventor: Mark Richard UNDERWOOD
  • ANTIVIRAL THERAPY
    Publication number: 20180098992
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 12, 2018
    Inventor: Mark Richard UNDERWOOD
  • ANTIVIRAL THERAPY
    Publication number: 20170281636
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: June 13, 2017
    Publication date: October 5, 2017
    Inventor: Mark Richard UNDERWOOD
  • ANTIVIRAL THERAPY
    Publication number: 20170216284
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: April 19, 2017
    Publication date: August 3, 2017
    Inventor: Mark Richard UNDERWOOD
  • ANTIVIRAL THERAPY
    Publication number: 20170119777
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: December 1, 2016
    Publication date: May 4, 2017
    Applicant: VIIV HEALTHCARE COMPANY
    Inventor: Mark Richard UNDERWOOD
  • ANTIVIRAL THERAPY
    Publication number: 20170079982
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: December 1, 2016
    Publication date: March 23, 2017
    Applicant: VIIV HEALTHCARE COMPANY
    Inventor: Mark Richard UNDERWOOD
  • ANTIVIRAL THERAPY
    Publication number: 20160339033
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
    Type: Application
    Filed: August 1, 2016
    Publication date: November 24, 2016
    Applicant: VIIV HEALTHCARE COMPANY
    Inventor: Mark Richard Underwood
  • ANTIVIRAL THERAPY
    Publication number: 20160199379
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: March 18, 2016
    Publication date: July 14, 2016
    Inventor: Mark Richard Underwood
  • ANTIVIRAL THERAPY
    Publication number: 20150238496
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents.
    Type: Application
    Filed: May 13, 2015
    Publication date: August 27, 2015
    Inventor: Mark Richard Underwood
  • Antiviral Therapy
    Publication number: 20120295898
    Abstract: The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
    Type: Application
    Filed: January 24, 2011
    Publication date: November 22, 2012
    Inventor: Mark Richard Underwood